Real-world experience of ocrelizumab in ms in the Turkish population: A single-center study

Ceylan, D.2024-11-062024-11-062022-07-011351-5101https://hdl.handle.net/11452/47452eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineClinical neurologyNeurosciencesNeurosciences & neurologyReal-world experience of ocrelizumab in ms in the Turkish population: A single-center studyMeeting Abstract00081525400332079279229Supplement1